Cover Image

Schisandra chinensis regulates drug metabolizing enzymes and drug transporters via activation of Nrf2-mediated signaling pathway

Jin-Lian He,1 Zhi-Wei Zhou,2,3 Juan-Juan Yin,2 Chang-Qiang He,1 Shu-Feng Zhou,2,3 Yang Yu1 1College of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People’s Republic of China; 2Department of Pharmaceutical Sciences, College of Pharmacy, University of So...

Full description

Saved in:

Bibliographic Details
Main Authors:	He JL (Author), Zhou ZW (Author), Yin JJ (Author), He CQ (Author), Zhou SF (Author), Yu Y (Author)
Format:	Book
Published:	Dove Medical Press, 2014-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Determination of eight lignans in Schisandra chinensis and Schisandra sphenanthera
by: Xu Guangyu, et al.
Published: (2016)

Determination of eight lignans in <i>Schisandra chinensis</i> and <i>Schisandra sphenanthera</i>
by: Xu Guangyu, et al.
Published: (2016)

Schisandra chinensis acidic polysaccharide partialy reverses acetaminophen-induced liver injury in mice
by: Jinying Che, et al.
Published: (2019)

Antioxidant Effects of <i>Schisandra chinensis</i> Fruits and Their Active Constituents
by: Dalia M. Kopustinskiene, et al.
Published: (2021)

Study on the Hepatoprotection of Schisandra chinensis Caulis Polysaccharides in Nonalcoholic Fatty Liver Disease in Rats Based on Metabolomics
by: Yanbo Feng, et al.
Published: (2021)

A Comprehensive Review of the Main Lignan Components of Schisandra chinensis (North Wu Wei Zi) and Schisandra sphenanthera (South Wu Wei Zi) and the Lignan-Induced Drug-Drug Interactions Based on the Inhibition of Cytochrome P450 and P-Glycoprotein Activities
by: Feng Zhang, et al.
Published: (2022)

A Study on the Fabrication of an Effective Natural Substance Based on Schisandra chinensis Extracted Fermentation
by: Nguyen CT, et al.
Published: (2021)

The study of biological active compounds of lipophilic fraction of Schisandra chinensis (Turcz.) Baill seeds
by: Inna Melnyk, et al.
Published: (2022)

Second-order calibration applied to quantification of two active components of Schisandra chinensis in complex matrix
by: Xiao-Hua Zhang, et al.
Published: (2012)

Screening of Q-markers for the wine-steamed Schisandra chinensis decoction pieces in improving allergic asthma
by: Zhongyuan Qu, et al.
Published: (2023)

Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies
by: Qiu JX, et al.
Published: (2015)

Schisandrin B inhibits cell growth and induces cellular apoptosis and autophagy in mouse hepatocytes and macrophages: implications for its hepatotoxicity
by: Zhang Y, et al.
Published: (2015)

Schisandra chinensis Stem Ameliorates 3-Nitropropionic Acid-Induced Striatal Toxicity via Activation of the Nrf2 Pathway and Inhibition of the MAPKs and NF-κB Pathways
by: Eun-Jeong Kim, et al.
Published: (2017)

The Cytochrome P450-Mediated Metabolism Alternation of Four Effective Lignans From Schisandra chinensis in Carbon Tetrachloride-Intoxicated Rats and Patients With Advanced Hepatocellular Carcinoma
by: Rongrong Wu, et al.
Published: (2018)

The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells
by: Li JP, et al.
Published: (2015)

Pharmacokinetic and nephroprotective benefits of using Schisandra chinensis extracts in a cyclosporine A-based immune-suppressive regime
by: Lai Q, et al.
Published: (2015)

Schisandra chinensis essential oil attenuates acetaminophen-induced liver injury through alleviating oxidative stress and activating autophagy
by: Jing Zhao, et al.
Published: (2022)

Inhibition of RANKL-stimulated osteoclast differentiation by Schisandra chinensis through down-regulation of NFATc1 and c-fos expression
by: Eun-Jung Kim, et al.
Published: (2018)

Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy
by: Bluth MH, et al.
Published: (2011)

A computational and functional study elicits the ameliorating effect of the Chinese herbal formula Huo Luo Xiao Ling Dan on experimental ischemia-induced myocardial injury in rats via inhibition of apoptosis
by: Han XD, et al.
Published: (2015)

Mechanistic Study of Schisandra chinensis Fruit Mixture Based on Network Pharmacology, Molecular Docking and Experimental Validation to Improve the Inflammatory Response of DKD Through AGEs/RAGE Signaling Pathway
by: Li H, et al.
Published: (2023)

Schisandra chinensis Bee Pollen Extract Inhibits Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells via Ferroptosis-, Wnt-, and Focal Adhesion–Signaling Pathways
by: Li Z, et al.
Published: (2024)

Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells
by: Pan ST, et al.
Published: (2015)

Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters
by: Teresa Iannaccone, et al.
Published: (2021)

Ethanol extract of Schisandrae chinensis fructus ameliorates the extent of experimentally induced atherosclerosis in rats by increasing antioxidant capacity and improving endothelial dysfunction
by: Xiu Chen, et al.
Published: (2018)

BIOPHARMACEUTICAL RESEARCHES IN VITRO ON THE CHOICE OF OPTIMAL COMPOSITION OF PHARMACEUTICAL AID FOR OINTMENT PRODUCTION BASED ON СО2 EXTRACT OF SCHISANDRA CHINENSIS SEEDS
by: Y. A. Morozov, et al.
Published: (2015)

Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells
by: Yuan CX, et al.
Published: (2015)

Investigating the Mechanism of Action of Schisandra chinensis Combined with Coenzyme Q10 in the Treatment of Heart Failure Based on PI3K-AKT Pathway
by: Wen S, et al.
Published: (2023)

Effects of diarylbutane lignans from Schisandra chinensis fruit on SARS-CoV-2 3CLpro and PLpro and their in vitro anti-inflammatory properties
by: Bin Li, et al.
Published: (2023)

Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline
by: Pablo Zubiaur, et al.
Published: (2022)

Effect of Genetic Variations in Drug-Metabolizing Enzymes and Drug Transporters on the Pharmacokinetics of Rifamycins: A Systematic Review
by: Sileshi T, et al.
Published: (2022)

Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells
by: Yuan CX, et al.
Published: (2015)

A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy
by: Christine Gong, et al.
Published: (2023)

The influence of genetic polymorphisms in drug metabolism enzymes and transporters on the pharmacokinetics of different fluvastatin formulations
by: Qian Xiang, et al.
Published: (2020)

Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study
by: Niu NK, et al.
Published: (2015)

Schisandra chinensis bee pollen's chemical profiles and protective effect against H2O2-induced apoptosis in H9c2 cardiomyocytes
by: Peiying Shi, et al.
Published: (2020)

Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication
by: He S, et al.
Published: (2015)

Drug-Drug Interactions at Organic Cation Transporter 1
by: Shiwei Zhou, et al.
Published: (2021)

Impact of pregnancy related hormones on drug metabolizing enzyme and transport protein concentrations in human hepatocytes
by: Muluneh M. Fashe, et al.
Published: (2022)

Characterizing drug-metabolizing enzymes and transporters that are bona fide CAR-target genes in mouse intestine
by: Shinhee Park, et al.
Published: (2016)